Cerevel Therapeutics Holdings
Stock Forecast, Prediction & Price Target
Cerevel Therapeutics Holdings Financial Estimates
Cerevel Therapeutics Holdings Revenue Estimates
Cerevel Therapeutics Holdings EBITDA Estimates
Cerevel Therapeutics Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $13.52M Low: $13.52M High: $13.52M avg. 0% | Avg: $67.17M Low: $67.17M High: $67.17M avg. 396.85% | Avg: $287.93M Low: $287.93M High: $287.93M avg. 328.63% | Avg: $706.63M Low: $706.63M High: $706.63M avg. 145.41% |
Net Income
% change YoY
| $-222.44M N/A | $-351.51M -58.02% | $-432.84M -23.13% | Avg: $-561.25M Low: $-534.78M High: $-412.11M avg. -29.66% | Avg: $-562.27M Low: $-487.78M High: $-372.72M avg. -0.18% | Avg: $-250.10M Low: $-250.10M High: $-250.10M avg. 55.51% | Avg: $-5.40M Low: $-5.40M High: $-5.40M avg. 97.84% |
EBITDA
% change YoY
| $-220.09M N/A | $-367.84M -67.12% | $-441.63M -20.05% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.63 N/A | -$2.32 -42.33% | -$2.67 -15.08% | Avg: -$2.88 Low: -$3.3 High: -$2.54 avg. -8.04% | Avg: -$2.69 Low: -$3.01 High: -$2.3 avg. 6.83% | Avg: -$1.54 Low: -$1.54 High: -$1.54 avg. 42.57% | Avg: -$0.03 Low: -$0.03 High: -$0.03 avg. 97.84% |
Operating Expenses
% change YoY
| $220.09M N/A | $367.84M 67.12% | $465.63M 26.58% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Cerevel Therapeutics Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 30.87% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -534.78M, average is -561.25M and high is -412.11M.
What is Cerevel Therapeutics Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 217.72% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $13.52M, average is $13.52M and high is $13.52M.
What is Cerevel Therapeutics Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 34.80% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$3.3, average is -$2.88 and high is $-2.54.
What is the best performing analyst?
In the last twelve months analysts have been covering Cerevel Therapeutics Holdings stock. The most successful analyst is Graig Suvannavejh whose win rate is 100%. He has correctly predicted 1/1 price targets.